<code id='BE126094BE'></code><style id='BE126094BE'></style>

<acronym id='BE126094BE'></acronym>

<center id='BE126094BE'><center id='BE126094BE'><tfoot id='BE126094BE'></tfoot></center><abbr id='BE126094BE'><dir id='BE126094BE'><tfoot id='BE126094BE'></tfoot><noframes id='BE126094BE'>

<optgroup id='BE126094BE'><strike id='BE126094BE'><sup id='BE126094BE'></sup></strike><code id='BE126094BE'></code></optgroup>

<b id='BE126094BE'><label id='BE126094BE'><select id='BE126094BE'><dt id='BE126094BE'><span id='BE126094BE'></span></dt></select></label></b><u id='BE126094BE'></u>

~~<i id='BE126094BE'><strike id='BE126094BE'><tt id='BE126094BE'><pre id='BE126094BE'></pre></tt></strike></i>~~

Home» leisure time» Wikipedia

Wikipedia

Wikipedia

author：fashion 2025-09-06 01:40:23 Page View：93

Johnson & Johnson sign — MARK RALSTON/AFP via Getty Images

WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.

J&J joins a flurry of litigation challenging the Medicare drug price negotiation program, which is set to start this fall. Merck, Bristol Myers Squibb, the brand-drug lobby PhRMA, and the U.S. Chamber of Commerce have also filed suit. The negotiated prices would go into effect in 2026.

advertisement

The company argued that it is entitled to sue because its blockbuster blood thinner drug Xarelto may be up for negotiation in the first round of ten drugs Medicare will examine, but that list is not set to be announced officially until Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Telehealth startups turn to complex chronic diseases
Next article： Peter Hotez and the public health issue of online harassment

explore

In age of alternative facts, a scholarly course on calling out crap

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Study: People of West African ancestry at greater risk of cardiac amyloidosis

AdobeAmongcardiologists,it’sknownthattransthyretincardiacamyloidosis,atypeofheartdisease,iscausedbyt

Medicare proposal to cover medical devices draws a mixed reaction

Medicare proposal to cover medical devices draws a mixed reaction

AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

eGenesis tests gene

Agene-editedYucatanminipigcreatedbyeGenesis.CourtesyLizLinder/eGenesisForthreedaysinDecember,anICUro

read more